Curcumin and long chain omega-3 fatty acids for management of cardiovascular health in individuals with type 2 diabetes

Not Applicable

Recruiting

• Conditions: Type 2 Diabetes; Metabolic and Endocrine - Diabetes; Cardiovascular - Other cardiovascular diseases

• Registration Number: ACTRN12616001483448
• Lead Sponsor: The University of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-10-25
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

This study is suitable for you if
You are aged between 40 and 75 years;
You are diagnosed with type 2 diabetes (duration less than 15 years)
Your body mass index (BMI) lies between 25 and 45 kg/m2

Exclusion Criteria

This study is not suitable for you if:
You are pregnant, planning to become pregnant or breastfeeding
Cannot provide informed consent
You have type 1 diabetes
You are currently on insulin treatment
You are diagnosed with cancer
You have a glomerular filtration rate less than 45
You have been diagnosed with painful peripheral neuropathy
You have a cardiac pacemaker
You have a history of severe neurological diseases (Parkinson’s, multiple sclerosis, epilepsy)
You are consuming more than 2 serves of oily fish per week
You are taking regular dietary supplements known to influence blood lipid levels
You have sensitivity/ intolerance to the products involved in this study
You are unwilling to fast for 10 hours before giving blood sample

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum Triglycerides<br>Serum Triglycerides will be analyzed by Hunter New England Area Pathology Services (HAPS)[At baseline (o day) and post intervention (42 day)<br>]